Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.
Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.
复制标题
DOI:
10.1158/1055-9965.epi-09-0591
复制
发表时间:
2009-11
期刊:
影响因子:
--
通讯作者:
Hankinson SE
中科院分区:
文献类型:
--
作者:
Eliassen AH;Ziegler RG;Rosner B;Veenstra TD;Roman JM;Xu X;Hankinson SE
Endogenous estrogens play an integral role in the etiology of breast, endometrial, and possibly ovarian cancer. Estrogen metabolism yields products that are potentially both estrogenic and genotoxic, yet individual metabolic patterns are just beginning to be explored in epidemiologic studies. Within the Nurses’ Health Study II, we examined reproducibility of 15 urinary estrogens and estrogen metabolites (EM) among 110 premenopausal women with three luteal phase urine samples collected over three years. EM were measured by a recently developed high-performance liquid chromatography-tandem mass spectrometry (LC-MS2) method with high sensitivity, specificity, and precision. We assessed Spearman correlations and intraclass correlation coefficients (ICCs) across the three samples. Correlations between urinary estrone or estradiol and the estrogen metabolites were only modest (r=0.1–0.5). The 2- and 4-hydroxylation pathways were highly correlated (r=0.9) but weakly inversely correlated with the 16-hydroxylation pathway (r=−0.2). Reproducibility within woman over time was fairly high for the three pathways, with ICCs ranging from 0.52 (16-hydroxylation pathway) to 0.72 (2-hydroxylation pathway). ICCs were similarly high for 2-catechols and the individual catechols (ICCs=0.58–0.72). Individual and grouped methylated 2-catechols had fairly high ICCs (0.51–0.62), but ICCs were low for the methylated 4-catechols (0.14–0.27). These data indicate that, in general, urinary EM levels vary substantially among individuals compared with intraindiviual variability. Reproducibility within person over time for most EM measures is comparable to or better than well-vetted biomarkers like plasma cholesterol and, in postmenopausal women, estradiol.